Details

Autor(en) / Beteiligte

• Minta, Anna A
• Ferrari, Matt
• Antoni, Sebastien
• Portnoy, Allison
• Sbarra, Alyssa
• Lambert, Brian
• Hatcher, Cynthia
• Hsu, Christopher H
• Ho, Lee Lee
• Steulet, Claudia
• Gacic-Dobo, Marta
• Rota, Paul A
• Mulders, Mick N
• Bose, Anindya Sekhar
• Caro, William Pere
• O'Connor, Patrick
• Crowcroft, Natasha S

Titel

Progress towards measles elimination--worldwide, 2000-2022/Progres accomplis dans le monde en vue de l'elimination de la rougeole, 2000-2022

Ist Teil von

• Weekly epidemiological record, 2023-11, Vol.98 (46), p.587

Ort / Verlag

World Health Organization

Erscheinungsjahr

2023

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Measles is a highly contagious, vaccine-preventable disease that requires high population immunity in order for transmission to be interrupted. All 6 WHO regions have committed themselves to eliminating measles; however, no region has achieved and sustained elimination. This report describes progress in measles elimination during 2000-2022. Estimated coverage with the first dose of measles-containing vaccine (MCV) worldwide increased from 72% to 86% between 2000 and 2019 and then decreased to 81% in 2021 during the coronavirus disease 2019 (COVID-19) pandemic, the lowest coverage rate since 2008. In 2022, MCV1 coverage increased to 83%. Only 72 (50%) of 144 countries that reported measles cases achieved the measles surveillance indicator target of >2 discarded cases per 100 000 population in 2022. During 2021-2022, estimated measles cases increased by 18%, from 7 802 000 to 9 232 300, and the number of countries experiencing large or disruptive outbreaks increased from 22 to 37. The estimated number of measles deaths increased by 43% during 2021-2022, from 95 000 to 136 200. Nonetheless, an estimated 57 million measles deaths were averted by vaccination during 2000-2022. In 2022, measles vaccination coverage and global surveillance showed some recovery from the setbacks during the COVID-19 pandemic; however, coverage decreased in low-income countries, and, globally, years of suboptimal immunization coverage left millions of children unprotected. Setbacks in coverage during the COVID-19 pandemic must be reversed by renewed efforts to vaccinate all children with 2 MCV doses, strengthen surveillance, prevent outbreaks and accelerate progress towards elimination.